MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-02-0010400
Slava Therapeutics Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2020
₹12.14 Cr
▲ 138% YoY
Net profit · FY 2020
₹18.41 Lakh
Net margin 1.5%
EBITDA · FY 2020
₹29.69 Lakh
EBITDA margin 2.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5.23 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
About Slava Therapeutics Private Limited
Data last updated:
Slava Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC118116. Its GSTIN is 36AAYCS9074K1Z8 (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sirisha Pilla and Mohana Krishna Gopinath.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2020, the company reported a revenue of ₹12.14 Cr, a growth of 138% compared to the previous year. For the same year it recorded a net profit of ₹18.41 Lakh (net margin 1.5%) and EBITDA of ₹29.69 Lakh (EBITDA margin 2.4%).
The company is associated with 1 brand: Slava Therapeutics. As per MCA filings, the company has open charges of ₹5.23 Cr on record. Court records list 14 cases involving the company, including 14 filed against it; 6 cases are pending.
Slava Therapeutics Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0010400). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website slavatherapeutics.com.
Company details
CIN U24304TG2017PTC118116
Registration Number 118116
Incorporation Date 06 July 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2020
Date of Balance Sheet 31 March 2020
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TS-02-0010400
Recognitions & Rankings of Slava Therapeutics
Contact details
Slava Therapeutics Private Limited's registered office is in Hyderabad, Telangana. Its website is slavatherapeutics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD No 15 – 29 – 1000/Hig – 129 Room No 3B Third Floor Pramani Plaza Phase 1&2 Kphb Colony Kukat, Pally, Hyderabad, Telangana, India – 500085
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Slava Therapeutics Private Limited, buy the company report.
Comprehensive company report
Slava Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Slava Therapeutics operates one associated brand: Slava Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of generic drugs | slavatherapeutics.com |
Business activity
The main business activity of Slava Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Slava Therapeutics Private Limited, buy the company report.
Financials of Slava Therapeutics Private Limited
FY 2020 filings availableSlava Therapeutics Private Limited reported revenue of ₹12.14 Cr (up 138% YoY) for FY 2020.
Revenue · FY 2020
₹12.14 Cr ▲ 138%
Net profit · FY 2020
₹18.41 Lakh margin 1.5%
EBITDA · FY 2020
₹29.69 Lakh margin 2.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 138%
EBITDA CAGR growth
1 year
▲ 161%
Revenue rose 138% in the latest year. EBITDA rose 161% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹12.14 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹29.69 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹18.41 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2.4% | ||
| Net Profit Margin | 1.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Slava Therapeutics Private Limited, buy the company report.
Board of directors of Slava Therapeutics Private Limited
Slava Therapeutics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sirisha Pilla Also directs: Antler Life Sciences Private Limited | Director | 06 Jul 2017 | 9 Years 4 Months | Current |
| Mohana Krishna Gopinath | Director | 13 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Slava Therapeutics Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kangrin and Boqe Pharmaceutical Private Limited | ₹12.19 Cr (FY 2024) | 39.0% | Thane, Maharashtra, India | |||
| Shilasagaram Enterprises Private Limited | ₹12.18 Cr (FY 2024) | -9.0% | Hyderabad, Telangana, India | |||
| Slava Therapeutics Private Limitedthis company | ₹12.14 Cr (FY 2020) | ₹18.41 Lakh | 1.5% | 138.0% | Hyderabad, Telangana, India | |
| Nandan Pharma Private Limited | ₹12.12 Cr (FY 2024) | 8.0% | Thane, Maharashtra, India | |||
| Arkas Pharma Private Limited | ₹12.05 Cr (FY 2024) | 1.0% | Hyderabad, Telangana, India | |||
| Originix Healthcare Private Limited | ₹12.03 Cr (FY 2020) | -17.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Slava Therapeutics Private Limited, buy the company report.
Auditor
Slava Therapeutics Private Limited is audited by D A Y & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D A Y & ASSOCIATES | FY 2020 | 011455S |
Shareholding
The shareholding of Slava Therapeutics Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Slava Therapeutics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.23 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Nov 2020 | 100417438 | Hdfc Bank Limited | ₹32.54 Lakh | Open | |
| 21 Mar 2020 | 100333848 | Others | ₹4.9 Cr | Open |
To see the full charge records of Slava Therapeutics Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Slava Therapeutics Private Limited has 14 court cases on record: 14 filed against it. 6 cases are pending and 8 are disposed.
Total cases
14
Filed against the company
14
Pending
6
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 13 | 6 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South, Delhi | Cheque dishonour complaint | Filed against the company by Axis Finance Ltd | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Ugro Capital Limited | Pending |
| High Court, West Bengal | Court case (EC) | Filed against the company by Ugro Capital Ltd Sinha and Co | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Lendingkart Finance Limited | Disposed |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Clix Capital Services Private Limited | Disposed |
To see the full case history of Slava Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Slava Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Slava Therapeutics has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAYCS9074K1Z8 | Telangana | Active | 23 Sep 2017 |
| 33AAYCS9074K1ZE | Tamil Nadu | Active | 05 Dec 2017 |
To see the full GST registrations and return filing status of Slava Therapeutics Private Limited, buy the company report.
Recent activity
Slava Therapeutics Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Chelluri Sunila ceased to be Director on 13 Nov 2020.
Charges
A charge with Others of Rs. 490.00 Lakh registered on 21 Mar 2020 with Charge ID 100333848 was modified on 28 Feb 2024.
AGM
Slava Therapeutics Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 32.54 Lakh with Charge ID 100417438 was registered on 21 Nov 2020.
Ceased
Chelluri Sunila ceased to be Director.
Appointed
Mohana Krishna Gopinath was appointed as Director.
Filing
Slava Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 490.00 Lakh with Charge ID 100333848 was registered on 21 Mar 2020.
Appointed
Sirisha Pilla was appointed as Director.
Incorporation
06 Jul 2017
Slava Therapeutics Private Limited was registered on 06 Jul 2017 with Roc Hyderabad & aged 9 years 4 months as per MCA records.
Frequently asked questions
Slava Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 July 2017 (9+ years old) and is registered under CIN U24304TG2017PTC118116.
Slava Therapeutics has 2 current directors:
- Sirisha Pilla - Director
- Mohana Krishna Gopinath - Director
The latest financial statements of Slava Therapeutics on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Slava Therapeutics is 36AAYCS9074K1Z8, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 33AAYCS9074K1ZE (Tamil Nadu).
The CIN (Corporate Identification Number) of Slava Therapeutics is U24304TG2017PTC118116. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Slava Therapeutics has 14 court cases on record: 14 filed against it. 6 are pending. Most are in the district courts.
Slava Therapeutics was incorporated on 06 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Slava Therapeutics by revenue are Kangrin and Boqe Pharmaceutical Private Limited, Shilasagaram Enterprises Private Limited, Nandan Pharma Private Limited, Arkas Pharma Private Limited, Originix Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Chelluri Sunila ceased to be Director on 13 Nov 2020. Mohana Krishna Gopinath was appointed as Director on 13 Nov 2020. Sirisha Pilla was appointed as Director on 06 Jul 2017.
Yes, Slava Therapeutics is registered as an MSME under Udyam registration (number: UDYAM-TS-02-0010400).
Slava Therapeutics can be reached through the website slavatherapeutics.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages